Table 1.

The clinical data and the individual concentrations of ECP, MPO, bFGF, VEGF and albumin in rectal perfusion fluid of CC patients before and after one and four weeks of treatment with steroids

Demography			Bowel movements			Mediators analyzed in Perfusion fluid
Patients	Age (yr)	Gender	per day			ECP (μg/L)			MPO (μg/L)			bFGF (pg/mL)			VEGF (pg/mL)			Albumin (mg/L)
												wk
			0	1	4	0	1	4	0	1	4	0	1	4	0	1	4	0	1	4
1	34	Female	3-4	0-1	0-1	3.7	< 2	< 2	29.1	14.9	< 8	14.03	18.26	0.65	299.7	92.8	41	20.3	44.6	< 2.1
2	57	Female	4	0-1	0-1	2.6	< 2	< 2	12.5	< 8	< 8	7.85	7.11	0.37	54.7	97	40.2	95.8	57.7	< 2.1
3	59	Female	10-12	0-1	0-1	3.6	7	< 2	< 8	< 8	< 8	1.21	4.1	< 0.25	113.1	146.7	81.1	20.3	10.7	3.4
4	43	Female	4-6	3-4	0-1	< 2	< 2	< 2	< 8	< 8	< 8	0.72	0.41	< 0.25	28.4	22.9	40.2	2.8	10.9	17.5
5	62	Female	3-4	0-1	0-1	< 2	< 2	< 2	< 8	< 8	11.3	0.35	< 0.25	0.29	66.2	46.6	53.1	2.7	10.7	5.5
7	66	Female	4-5	0-1	0-1	< 2	< 2	< 2	< 8	< 8	< 8	< 0.25	< 0.25	< 0.25	58.8	19.1	22.2	3.9	6.5	3.2
8	59	Female	5-10	2	0-1	6.5	< 2	< 2	< 8	< 8	< 8	5.28	< 0.25	0.35	86.1	37.8	58.8	17.1	3.1	2.3
9	64	Female	3	0-1	0-1	< 2	< 2	< 2	< 8	< 8	< 8	< 0.25	< 0.25	< 0.25	17.6	9.6	12.3	5	< 2.1	7
10	39	Male	7-10	2-3	0-1	< 2	< 2	< 2	< 8	< 8	< 8	2.7	1.21	< 0.25	100.4	94.5	90.3	43	13.7	11.7
11	34	Female	5-6	2	0-1	3.1	< 2	< 2	18.3	< 8	< 8	11.99	2.35	< 0.25	153.6	84.4	80.2	116	22.1	10.7
12	53	Male	6-7	2-3	0-1	2.3	< 2	< 2	< 8	< 8	< 8	12.29	0.91	0.61	95.3	48.2	29.1	21.5	5.2	< 2.1